Australian Antitrust Agency OKs Baxter's $4B Gambro Buy
Australia's antitrust regulator on Wednesday said it won't oppose Baxter International Inc.'s $4 billion bid for Swedish dialysis product maker Gambro AB since Baxter plans to sell part of its unit...To view the full article, register now.
Already a subscriber? Click here to view full article